Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer
Silvia Mara Baez Rodriguez, Georgiana-Adeline Staicu, Ani-Simona Sevastre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4602-4602
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
Silvia Mara Baez Rodriguez, A. El Kamel, Gheorghe Vasile Ciubotaru, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11110-11110
Open Access | Times Cited: 39
The hidden architects of glioblastoma multiforme: Glioma stem cells
Om Saswat Sahoo, Rhiti Mitra, Naveen KH Nagaiah
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
The HOX Gene Family’s Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors
Kaci Kopec, Danielle Quaranto, Nicole R. DeSouza, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 262-262
Open Access
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
Andrew M. Hersh, Hallie Gaitsch, Safwan Alomari, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3743-3743
Open Access | Times Cited: 28
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
Tzu‐Jen Kao, Chien-Liang Lin, Wen‐Bin Yang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 3
Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells
Jorge A. Peña Agudelo, Matías L. Pidre, Matías Garcia Fallit, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4061-4061
Open Access | Times Cited: 9
The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives
Dariusz Łaszczych, Aleksandra Czernicka, Karol Gostomczyk, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Open Access | Times Cited: 2
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 2
The effect of Azo-dyes on glioblastoma cells in vitro
Ani-Simona Sevastre, Carina Baloi, Oana Alexandru, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 3, pp. 103599-103599
Open Access | Times Cited: 7
Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma
Tingyu Liang, Yixuan Song, Lingui Gu, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4121-4141
Open Access | Times Cited: 6
Evaluation of the Antitumor Potential of Soloxolone Tryptamide against Glioblastoma Multiforme Using in silico, in vitro, and in vivo Approaches
Andrey V. Markov, Kirill V. Odarenko, Aleksandra V. Sen’kova, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 7, pp. 1008-1021
Open Access | Times Cited: 5
Ribosomes and Ribosomal Proteins Promote Plasticity and Stemness Induction in Glioma Cells via Reprogramming
Takuichiro Hide, Ichiyo Shibahara, Madoka Inukai, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2142-2142
Open Access | Times Cited: 9
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
Manxi Ge, Yan Zhu, Minjie Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188996-188996
Closed Access | Times Cited: 4
Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview
Ahmed Ismail Eatmann, Esraa Hamouda, Heba Hamouda, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 543-543
Open Access | Times Cited: 4
Nicotinamide Adenine Dinucleotide Phosphate Oxidase Promotes Glioblastoma Radiation Resistance in a Phosphate and Tensin Homolog-Dependent Manner
Kirsten Ludwig, Janel E. Le Belle, Sree Deepthi Muthukrishnan, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 13-15, pp. 890-903
Closed Access | Times Cited: 3
Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma
Mohsen Keshavarz, Hassan Dianat‐Moghadam, Seyedeh Sara Ghorbanhosseini, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 9, pp. 130662-130662
Closed Access
Structural, Quantum Chemical, Spectroscopic (UV, FT-IR, and NMR), and Molecular Docking Studies of Novel Azo Compounds
Ceyhun Kucuk, Nurdan Akdoğan, Kenan Özel, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139318-139318
Closed Access
Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access
Exploring miRNA therapies and gut microbiome–enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting
K. Sandhanam, Tamilanban Thamaraikani, Bedanta Bhattacharjee, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Curcumin and 2-DG synergistically target the glio-oncogenesis trigger IL-6 and down-regulate the stemness in glioblastoma model in-vitro
Kavita Peter, Puneet Gandhi, Santosh Kar
Advances in Traditional Medicine (2024)
Closed Access
Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs
Daria Lanskikh, Olga Kuziakova, Ivan Baklanov, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2085-2085
Open Access
Glioblastoma - Current Evidence

IntechOpen eBooks (2022)
Open Access | Times Cited: 1
Stem Cell Therapy For Glioblastoma
Abby Lin, Vincent S. Gallicchio
Journal Of Stem Cell Research (2023) Vol. 4, Iss. 1, pp. 1-12
Open Access
Editorial: Special Issue “Stem Cell Biology and Cancer”
Carolina Vicente‐Dueñas, Isidro Sánchez‐García, G. E. Brown
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11533-11533
Open Access
Page 1 - Next Page

Scroll to top